Dow Emerson

Children's Hospital of Richmond at VCU

Papers

1

Total Citations

18

H-Index

1

About

Dow Emerson is a leading figure in urologic oncology, with a focused expertise in renal cancer surgery and nephrometry scoring systems. His major contribution lies in advancing the precision of preoperative tumor assessment through the development and validation of the Simplified PADUA Renal (SPARE) nephrometry scoring system. This work, highlighted in his most-cited paper (2020, 18 citations), provides a streamlined, reproducible tool for predicting surgical complexity and outcomes in robotic partial nephrectomy. Emerson’s research has significantly enhanced clinical decision-making by demonstrating the SPARE system’s strong interobserver variability and superior comparability to established RENAL and PADUA scores. His impact is evident in the growing adoption of simplified scoring methods to improve patient counseling and surgical planning. Beyond this, Emerson’s work underscores a commitment to minimizing surgical morbidity while maximizing oncologic control, making him a key contributor to the evolution of nephron-sparing surgery. His achievements reflect a blend of rigorous validation and practical application, offering valuable insights for both trainees and seasoned surgeons navigating complex renal masses.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Simplified PADUA Renal (SPARE) Nephrometry Scoring System: External Validation, Interobserver Variability, and Comparison with RENAL and PADUA in a Single-center Robotic Partial Nephrectomy Series
18 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Children's Hospital of Richmond at VCU

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago